Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0086543 (cataract)
 29,165 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Traditional cataract operation (dislocation of the crystalline lens into the vitreous body by external pressure or by needling) is nearly as old as mankind. The idea of implanting an artificial lenticulus is not new but this was only performed for the first time in 1949. In the last 50 years, a better knowledge of corneal and retinal physiology, as well as the improvements of intraocular lens material and design, have led to very safe routine surgery.
Bull Mem Acad R Med Belg 1999
PMID:[The artificial lens: the folly of yesterday, the standard of today]. 1068 45

A new intraocular lens (LOL) aiming at eradicating posterior capsule opacification (PCO), the most common complication after cataract surgery, is proposed. The haptics of this new IOL are conceived to capture the remaining lens epithelial cells (LECs) left behind in the capsular equator after cataract surgery in a closed area in order not to allow them to proliferate into the visual axis. In order to facilitate the surgical technique, several devices have been developed. We showed the inocuity of this technique on postoperative inflammation and the low rate of postoperative complications. We obtained 0% PCO and in addition excellent refractive results. The results on children and babies were the most rewarding since none of these children presented PCO and accommodation was important enough as to allow reading without glasses.
Bull Mem Acad R Med Belg 2006
PMID:[Secondary cataract: a problem resolved]. 1730 77

Sir Harold Ridley invented and refined the modern miracle of replacing lenses obscured by cataracts with plastic optical lenses, thus rendering a complete cataract cure. This operation, broadly termed the cataract-intraocular lens (IOL) operation, has since brought sight to many millions of people throughout the world, and continues to improve the quality of life of more than 10 million patients worldwide each year. Ridley not only launched this powerful and irreversible forward movement in the field of ophthalmology and the visual sciences, but through it he also helped give birth to the exciting and new field of artificial biodevice implantation as well as transplantation techniques now applied to many other organs and tissues of the body. He has therefore been credited with healing to create the relatively new specialty of biomedical engineering. Few of the millions of patients worldwide who now enjoy the benefits of the modern cataract - IOL operation are aware of the origin of this innovation. Indeed, few eye care professionals - even ophthalmic surgeons who implant them almost daily - are aware of the origin of the IOL - an invention that, as Harold himself liked to say, 'cured aphakia'. (The word aphakia comes from teh Greek, meaning absence of lens, the situation that occurs when a cataractous lens is surgically removed.)
Biogr Mem Fellows R Soc 2007
PMID:Sir Nicholas Harold Lloyd Ridley: 10 July 1906 - 25 May 2001. 1854 67